by Katie Galvin | May 28, 2021 | What’s new?
28th May 2021 Missed our GatewayC Live webinar? Watch the recording here. In this webinar, GatewayC met Dr Rory Harvey, Consultant Gastroenterologist at Bedfordshire Hospitals NHS Foundation Trust. In this webinar, we explored the role and benefits of using the faecal...
by Katie Galvin | Sep 10, 2020 | All Cancer Keys
10th September 2020 Potential pitfall: Faecal calprotectin testing is an incredibly sensitive investigation for detecting the presence of inflammation. It is raised in a wide variety of conditions including malignancy, inflammatory bowel disease and alcohol misuse. It...
by Katie Galvin | Jul 31, 2020 | All Cancer Keys
31 July 2020 Potential pitfall: A negative bowel screening test should not be used to make decisions about referral in a symptomatic patient. Sensitivity levels have been set very differently for screening and symptomatic Faecal Immunochemical Tests (FIT). Helpful...
by Anna Perkins | Nov 1, 2019 | All Cancer Keys
1st November 2019 Whilst FIT can be a good indicator of bowel cancer, inflammatory bowel disease and sometimes precursors of cancer, some symptomatic patients can still have false negative results. With this in mind, how should you proceed? Potential Pitfall A normal...
by Anna Perkins | Oct 18, 2019 | All Cancer Keys
18th October 2019 The new Faecal Immunochemical Test (FIT) rolled out across England this year has a number of benefits in replacing the use of older guaiac-based faecal occult blood tests (gFOBTs). Is your practice up to date with the new processes associated with...
Recent Comments